Rankings
▼
Calendar
KYMR FY 2025 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
KYMR
Kymera Therapeutics, Inc.
$7B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$39M
-16.7% YoY
Gross Profit
$39M
100.0% margin
Operating Income
-$349M
-891.3% margin
Net Income
-$311M
-794.4% margin
EPS (Diluted)
$-3.69
Cash Flow
Operating Cash Flow
-$233M
Free Cash Flow
-$234M
Stock-Based Comp.
$60M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$163M
Stockholders' Equity
$1.6B
Cash & Equivalents
$357M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$39M
$47M
-16.7%
Gross Profit
$39M
$47M
-16.7%
Operating Income
-$349M
-$262M
-33.5%
Net Income
-$311M
-$224M
-39.1%
← Q4 2024
All Quarters
Q1 2025 →